Jessemae L. Welsh

Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial

Jessemae L. Welsh, Brett A. Wagner, Thomas J. van ‘t Erve et al. · Cancer Chemotherapy and Pharmacology · 2013 · 297 citations · Full text

Oncology, Pancreatic Cancer, Pharmacology +5

Pharmacological Ascorbate Radiosensitizes Pancreatic Cancer

Juan Du, John A. Cieslak, Jessemae L. Welsh et al. · Cancer Research · 2015 · 109 citations

Pharmacologic Ascorbate, Pancreatic Cancer, Radiation Therapy +10

Clinical Decision-Making in Patients with Variant of Uncertain Significance in BRCA1 or BRCA2 Genes

Jessemae L. Welsh, Tanya L. Hoskin, Courtney N. Day et al. · Annals of Surgical Oncology · 2017 · 94 citations · Full text

Brca2 Genes, Oncology, Clinical Decision-making +10

Manganoporphyrins Increase Ascorbate-Induced Cytotoxicity by Enhancing H2O2 Generation

Malvika Rawal, Samuel R. Schroeder, Brett A. Wagner et al. · Cancer Research · 2013 · 77 citations

Redox Signaling, Chemoprevention Strategy, Biochemistry +15

Predicting Nodal Positivity in Women 70 Years of Age and Older with Hormone Receptor-Positive Breast Cancer to Aid Incorporation of a Society of Surgical Oncology Choosing Wisely Guideline into Clinical Practice

Jessemae L. Welsh, Tanya L. Hoskin, Courtney N. Day et al. · Annals of Surgical Oncology · 2017 · 68 citations

Breast Oncology, Endocrine-related Cancer, Medicine +10